| Birth control (4) |  |
| Contraception (4) | |
| Sterilisation (3) | |
| Birth control (4) | |
| Contraception (4) | |
| Sterilisation (3) | |
The difference is that Ovastasis plans to use those protein biomarkers as targets for a novel female birth control medication. he identification of drug targets that are selective to the egg
Currently approved female birth control medications work by manipulating the female body estrogen and progesterone levels. While effective, these drugs are steroids
Ovastasis is developing a new form of birth control that will interact only with a woman reproductive cells to arrest their development.
The same biomarkers that will help limit the area of impact for Ovastasis birth control will also help Neoantigenics confine the toxic effects of cancer treatment to growing egg and tumor cells.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011